# MiMedx Group, Inc. – FDA Inspection, Mar 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/495a9599-303b-4b00-9b51-d82febc2ac7a
Source feed: FDA_Inspections

> FDA inspection 1198732 of MiMedx Group, Inc., March 02, 2023. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198732
- Company Name: MiMedx Group, Inc.
- Inspection Date: 2023-03-02
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 6
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1112843 - 2019-12-12](https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/1435ccd2-4ab5-4cff-850f-38e6beb19f63)
- FDA Inspection 1069242 - 2018-09-26

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)
- [FDA Associated Person](https://www.keypedia.com/people/cody-d-rickman/54deec25-dc65-4402-991a-ad5589bad78b)
- [Issuing Officer](https://www.keypedia.com/people/marla-a-cassidy/d2859ca5-e77b-4385-9a96-4c785f3ac4c6)

Company: https://www.keypedia.com/companies/mimedx-group-inc/48cc856a-f21d-4488-bbbd-4428f7bf1308

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
